{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:12Z","timestamp":1760145972991,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Patients with hematological malignancies (HMs) are at high risk of respiratory viral infections due to the intrinsic deterioration of the immune system and chemotherapy treatments. In the recent past, SARS-CoV-2 respiratory viral infection has been responsible for most infectious complications in HMs. We analyzed 2950 samples from 505 patients admitted to the Hematology department from 2019 to 2023. The aim of this study was to determine the epidemiological trend of respiratory viruses in the SARS-CoV-2 era, the characteristics of the patients involved and their outcomes. In our analysis, we found a reduction in non-SARS-CoV-2 respiratory viral (NSRV) positivity during the pandemic period, although these data did not show statistical significance. Most of the HMs involved were Multiple Myeloma and Acute Myeloid Leukemia. Overall mortality rate was very low and characterized by the progression of the HMs as well as the worsening of respiratory failure. In conclusion, a reduction in non-COVID viral infections was highlighted, probably also thanks to the increase in prevention measures and environmental modifications of the viral background.<\/jats:p>","DOI":"10.3390\/v16101520","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T04:05:46Z","timestamp":1727323546000},"page":"1520","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies"],"prefix":"10.3390","volume":"16","author":[{"given":"Antonio","family":"Giordano","sequence":"first","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"},{"name":"Hematology Department, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli, 8 I-00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Quattrone","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Viscovo","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fiori","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Santangelo","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9780-7059","authenticated-orcid":false,"given":"Maurizio","family":"Sanguinetti","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"},{"name":"Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universit\u00e0 Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-928X","authenticated-orcid":false,"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 8 I-00168 Roma, Italy"},{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Universit\u00e0 Cattolica del Sacro Cuore, 8 I-00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.cell.2021.08.017","article-title":"The origins of SARS-CoV-2: A critical review","volume":"184","author":"Holmes","year":"2021","journal-title":"Cell"},{"key":"ref_2","unstructured":"World Health Organization (2024, September 02). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201311 March 2020, Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Garc\u00eda, L.F. (2020). Immune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01441"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104227","DOI":"10.1016\/j.ejmg.2021.104227","article-title":"Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19","volume":"64","author":"Monticelli","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2019.02.004","article-title":"Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient","volume":"33","author":"Fontana","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: A European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood.2022017257","article-title":"Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: Results from the EPICOVIDEHA survey","volume":"140","author":"Pagano","year":"2022","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/hon.3240","article-title":"Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry","volume":"42","author":"Musto","year":"2023","journal-title":"Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3324\/haematol.2018.215152","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"104","author":"Khawaja","year":"2019","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: A retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Popescu, C.M., Ursache, A.L., Feketea, G., Bocsan, C., Jimbu, L., Mesaros, O., Edwards, M., Wang, H., Berceanu, I., and Neaga, A. (2019). Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients?. Microorganisms, 7.","DOI":"10.3390\/microorganisms7110521"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40121-020-00313-6","article-title":"Viral Respiratory Infections in Hematological Patients","volume":"9","author":"Gabutti","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hijano, D.R., Maron, G., and Hayden, R.T. (2018). Respiratory Viral Infections in Patients with Cancer or Undergoing Hematopoietic Cell Transplant. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.03097"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijid.2020.11.127","article-title":"Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients","volume":"102","author":"Li","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1631\/jzus.B2000479","article-title":"Comparison of COVID-19 and influenza characteristics","volume":"22","author":"Bai","year":"2021","journal-title":"J. Zhejiang Univ. B"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Micozzi, A., Gentile, G., Minotti, C., Cartoni, C., Capria, S., Ballar\u00f2, D., Santilli, S., Pacetti, E., Grammatico, S., and Bucaneve, G. (2017). Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: Factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2297-9"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/myc.13056","article-title":"Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey","volume":"63","author":"Lanternier","year":"2020","journal-title":"Mycoses"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yang, N., Zhang, L., and Feng, S. (2023). Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies. J. Fungi, 9.","DOI":"10.3390\/jof9050592"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e32245","DOI":"10.1097\/MD.0000000000032245","article-title":"Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients","volume":"101","author":"Raymond","year":"2022","journal-title":"Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ryoo, J., Kim, S.C., and Lee, J. (2024). Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy. BMC Pulm. Med., 24.","DOI":"10.1186\/s12890-024-03071-0"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/10\/1520\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:03:22Z","timestamp":1760112202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/10\/1520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["v16101520"],"URL":"https:\/\/doi.org\/10.3390\/v16101520","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}